Literature DB >> 6127686

Inhibitory postsynaptic currents at Aplysia cholinergic synapses: effects of permeant anions and depressant drugs.

D J Adams, P W Gage, O P Hamill.   

Abstract

Inhibitory postsynaptic potentials (i.p.s.ps) and, under voltage-clamp conditions, inhibitory postsynaptic currents (i.p.s.cs) were recorded in neurons in buccal ganglia of Aplysia juliana. The decay of i.p.s.cs was exponential with a single time constant, tau, which decreased with membrane depolarization. In external solutions containing iodide or bromide ions instead of chloride ions, tau varied according to the sequence tau (I) greater than tau (Br) greater than tau (Cl), and the voltage sensitivity of tau was altered. In iodide solution, the voltage sensitivity of tau was reversed. Furthermore, the foreign halides depressed the peak current amplitude and shifted the reversal (zero-current) potential to more positive membrane potentials. In low concentrations of sodium pentobarbitone (100-200 microns), the decay of i.p.s.cs became biphasic. Increasing drug concentration and membrane hyperpolarization had differential effects on the rates and relative amplitudes of the two components of i.p.s.c. decay. Octanol (0.5-1 mM) reduced the amplitude of i.p.s.ps and increased the rate of decay of i.p.s.cs without changing the voltage sensitivity of tau. The effect of foreign halides and barbiturates on i.p.s.c. decay were interpreted in terms of a reaction between the anion and an ion-binding site(s) associated with the anion-selective channel, which affects the probability of anions entering the channel and normal channel closure.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6127686     DOI: 10.1098/rspb.1982.0015

Source DB:  PubMed          Journal:  Proc R Soc Lond B Biol Sci        ISSN: 0950-1193


  12 in total

1.  Ion effects on gating of the Ca(2+)-activated K+ channel correlate with occupancy of the pore.

Authors:  S D Demo; G Yellen
Journal:  Biophys J       Date:  1992-03       Impact factor: 4.033

2.  Outward rectification of inhibitory postsynaptic currents in cultured rat hippocampal neurones.

Authors:  J L Barker; N L Harrison
Journal:  J Physiol       Date:  1988-09       Impact factor: 5.182

3.  Acetylcholine receptors in spider peripheral mechanosensilla.

Authors:  Alexandre Widmer; Izabela Panek; Ulli Höger; Shannon Meisner; Andrew S French; Päivi H Torkkeli
Journal:  J Comp Physiol A Neuroethol Sens Neural Behav Physiol       Date:  2005-09-24       Impact factor: 1.836

4.  Some effects of procaine at the toad end-plate are not consistent with a simple channel-blocking model.

Authors:  P W Gage; R E Wachtel
Journal:  J Physiol       Date:  1984-01       Impact factor: 5.182

5.  Analysis of glycine-activated inhibitory post-synaptic channels in brain-stem neurones of the lamprey.

Authors:  M R Gold; A R Martin
Journal:  J Physiol       Date:  1983-09       Impact factor: 5.182

6.  Action of enflurane on cholinergic transmission in identified Aplysia neurones.

Authors:  H Arimura; Y Ikemoto
Journal:  Br J Pharmacol       Date:  1986-11       Impact factor: 8.739

7.  Actions of anaesthetics and avermectin on GABAA chloride channels in mammalian dorsal root ganglion neurones.

Authors:  B Robertson
Journal:  Br J Pharmacol       Date:  1989-09       Impact factor: 8.739

8.  Receptor-mediated presynaptic facilitation of quantal release of acetylcholine induced by pralidoxime in Aplysia.

Authors:  P Fossier; G Baux; B Poulain; L Tauc
Journal:  Cell Mol Neurobiol       Date:  1990-09       Impact factor: 5.046

9.  Miniature and evoked inhibitory junctional currents and gamma-aminobutyric acid-activated current noise in locust muscle fibres.

Authors:  S G Cull-Candy
Journal:  J Physiol       Date:  1986-05       Impact factor: 5.182

10.  Use of 82Br- radiotracer to study transmembrane halide flux: the effect of a tranquilizing drug, chlordiazepoxide on channel opening of a GABAA receptor.

Authors:  D J Cash; P Serfözö; K Zinn
Journal:  J Membr Biol       Date:  1995-06       Impact factor: 1.843

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.